Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease

Md Sayed Ali Sheikh1, Ke Xia2, Fei Li1

  • 1Department of Cardiology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha, Hunan 410078, China.

Insights

Circulating miR-765 and miR-149 show promise as noninvasive biomarkers for early detection of coronary artery disease (CAD) in geriatric patients. These microRNAs offer significant diagnostic value for identifying stable and unstable CAD in the elderly.

Area of Science:

  • Biochemistry
  • Gerontology
  • Cardiovascular Medicine

Background:

  • Coronary artery disease (CAD) poses a significant health challenge in the geriatric population.
  • Current diagnostic methods for CAD can be invasive and may pose risks to elderly patients.
  • The need for noninvasive early diagnostic biomarkers for geriatric CAD is critical.

Purpose of the Study:

  • To evaluate the diagnostic utility of circulating miR-765 and miR-149 as noninvasive early biomarkers for geriatric coronary artery disease (CAD).

Main Methods:

  • A cohort of 69 geriatric patients with angiographically confirmed CAD (37 stable, 32 unstable) and 20 healthy controls were enrolled.
  • Plasma levels of miR-765 and miR-149 were measured and compared between CAD patients and controls.
  • Receiver Operating Characteristic (ROC) curve analysis was performed to assess diagnostic accuracy.

Main Results:

  • Circulating miR-765 levels were significantly elevated in both stable (2.9-fold) and unstable (5.8-fold) CAD patients compared to controls.
  • Circulating miR-149 levels were significantly downregulated in stable (3.5-fold) and unstable (4.2-fold) CAD patients compared to controls.
  • Both miR-765 and miR-149 demonstrated high diagnostic accuracy (AUC > 0.938) for differentiating CAD patients from healthy subjects.

Conclusions:

  • Plasma miR-765 and miR-149 exhibit significant potential as noninvasive biomarkers for the early diagnosis of coronary artery disease in geriatric individuals.
  • These microRNAs could aid in the early detection and management of CAD, reducing the need for invasive procedures in the elderly.
  • Further research is warranted to validate these findings in larger, diverse geriatric populations.